Financials
- Market Capitalization 2.67 M
- Employee 11
- Founded 2007
- CEO N/A
- Website www.organovo.com
- Headquarter Delaware, United States
- FIGI BBG001M8GFD0
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.27
売上高対価格比率
28.25
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4848 | QCLS Q/C Technologies, Inc. - Common Stock | 0.55 USD | -5.17% | -20.29% | -65.63% | -85.68% | 4.50 M USD | ||
| 4913 | KAPA Kairos Pharma, Ltd. Common Stock | 0.80 USD | -3.61% | -25.93% | -53.22% | +37.93% | 2.71 M USD | ||
| 4921 | PPCB Propanc Biopharma, Inc. - Common Stock | 0.41 USD | -6.82% | -16.33% | -54.44% | -77.26% | 2.60 M USD | ||
| 5016 | DCOY Decoy Therapeutics Inc. - Common Stock | 1.28 USD | -10.49% | -17.42% | -56.76% | +58.26% | 838.64 K USD |